Michelle Solly

@MSollender

The Lady Who Can Tell Time. Currently Taking Care of My Chicken

California, USA
Vrijeme pridruživanja: studeni 2018.

Tweetovi

Blokirali ste korisnika/cu @MSollender

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MSollender

  1. Prikvačeni tweet
    30. pro 2019.

    Time to start planning for 2020? Some events through mid 2020, courtesy of Jefferies to keep an eye on: First, companies in their coverage >$1B mcap

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 43 minute

    private placement. 2.5M shares at $50/share

    Poništi
  3. proslijedio/la je Tweet
    prije 1 sat
    Poništi
  4. proslijedio/la je Tweet
    prije 5 sati

    Beam Therapeutics, Inc. (BEAM) priced 10.6mm shares (upsized from 9.25mm & upsized earlier from 6.25mm) at the high-end of the range, $17.00, and will debut on Thursday. 

    Poništi
  5. prije 5 sati

    Analyst is Vamil Divan

    Prikaži ovu nit
    Poništi
  6. prije 6 sati

    Mizuho initiating in Biopharmaceuticals - Buy, $96 - Neutral, $148 - Buy, $42 - Neutral, $19 - Assume Buy, $20 - Neutral, $107 - Buy, $62 - Buy, $120 - Neutral, $69 - Buy, $37

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    prije 6 sati
    Poništi
  8. proslijedio/la je Tweet
    prije 9 sati

    *BIOGEN WINS MYLANS CHALLENGE TO PATENT ON TECFIDERA

    Poništi
  9. proslijedio/la je Tweet
    prije 10 sati

    Today's call possibly moving at least two stocks. Positive mention of Lenvatinib ( ) and vericiguat and sGC, which was called an "important area" ( )

    Poništi
  10. proslijedio/la je Tweet
    4. velj

    Ziopharm to Offer Shares Said at $3.25/Share

    Poništi
  11. 4. velj
    Poništi
  12. 4. velj

    Offering

    Poništi
  13. proslijedio/la je Tweet
    3. velj

    Feb-Mar '20 catalysts P3 Prevention P3 TRD P3 CLL P3 DED P3 BOSTON P3 EM P3 cUTI P2 WILLOW P2b MS P2a GO P2a NTM P1/2 Usher Adu Filing : PDUFAs:

    Poništi
  14. 3. velj

    Gene therapy company founded by James Wilson, targeting CNS Initiating trials in GM1 gangliosidosis and frontotemporal dementia in 1H20 $110m Series B in Sept19 New investors: Boxer, Highline, Logos, Sphera Existing: Orbimed, Frazier, Versant, Lily Asia, New Leaf, Vivo

    Poništi
  15. proslijedio/la je Tweet
    3. velj

    The latest Sugarcone Biotech post explores new horizons on the changing landscape. A must read.

    Poništi
  16. proslijedio/la je Tweet
    31. sij
    Poništi
  17. proslijedio/la je Tweet
    31. sij

    Arcutis Biotherapeutics Inc. (ARQT) priced 9.4mm shares (upsized from 7.8mm) at the high-end of the range, $17.00, and opened at $23.05 for a gain of 35.6% at first trade. 

    Poništi
  18. proslijedio/la je Tweet
    31. sij

    Good analysis of from Daina of SVBLeerink -Focus now on anti-APRIL in IgAN -Well below cash -Cutting STING related burn I've seen this phoenix from the ashes story before, e.g. What are your fav phoenix from ashes names? No rev mergers

    Prikaži ovu nit
    Poništi
  19. 30. sij

    Offering + pre-funded warrants

    Poništi
  20. proslijedio/la je Tweet
    30. sij

    discontinues P1 of its Nav1.8 in pain

    Poništi
  21. proslijedio/la je Tweet

    The Swiss pharma company Roche has developed what it believes is the first commercially available diagnostic test for the new coronavirus. Follow live updates and analysis here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·